INCY

MKT CAP:$19B

Incyte Corporation

Market Cap

$19B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$100.64-$0.78 (-0.77%)

Jun 8, 2026

52W High $110.5752W Low $67.26

Company Details

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF)...

CEO

—

IPO Date

Nov 4, 1993

Website

www.incyte.com

Key Metrics TTM

Revenue

$5.4B

+21.5% YoY

Net Income

$1.4B

EPS (Diluted)

Free Cash Flow

$1.5B

Revenue / Share

$25.92

Gross Margin

92.5%

Operating Margin

27.1%

Net Margin

26.7%

FCF Margin

27.1%

P/S

3.6x

P/E

13.3x

Earnings Reports

Q2 2026

Jul 28, 2026

PENDING

Q1 2026

Apr 28, 2026

$1.3B+20.9%

FY 2025

Feb 10, 2026

$5.1B+21.2%

Q4 2025

Feb 10, 2026

$1.5B+27.8%

Q3 2025

Oct 28, 2025

$1.4B+20.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee